Evidence map›Paper›PMID 33133215›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2020

Tianma Gouteng Decoction Exerts Cardiovascular Protection by Upregulating OPG and TRAIL in Spontaneously Hypertensive Rats.

Lin-Hua Deng, Lan Li, You Zhai, Sarhene Michael, Chun-Yang Yang, Rui Guo, Shan-Fu Chen, Guan-Wei Fan, Ying-Qiang Zhao, Wei Liu

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Frontiers in aging neuroscience · 2024
    Article
  3. 4,4'-methylenediphenol reduces Aβ-induced toxicity in aFrontiers in aging neuroscience · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Lin-Hua DengSecond Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.ORCID https://orcid.org/0000-0001-9798-0815
Lan LiTianjin University of Traditional Chinese Medicine, Tianjin, China.
You ZhaiSecond Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.
Sarhene MichaelTianjin University of Traditional Chinese Medicine, Tianjin, China.
Chun-Yang YangTianjin University of Traditional Chinese Medicine, Tianjin, China.
Rui GuoTianjin University of Traditional Chinese Medicine, Tianjin, China.
Shan-Fu ChenTianjin University of Traditional Chinese Medicine, Tianjin, China.
Guan-Wei FanFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Ying-Qiang ZhaoSecond Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.ORCID https://orcid.org/0000-0002-9731-5433
Wei LiuSecond Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.ORCID https://orcid.org/0000-0002-9901-0641
Tianjin University of Traditional Chinese Medicine · CNFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tianma Gouteng Decoction (TGD) is widely used in traditional Chinese medicine for the treatment of hypertension and its related complications, but its mechanisms remain incompletely defined. We now aim to assess the protective effect of TGD against cardiovascular damage and to investigate its characteristics and underlying mechanisms. Blood pressure was determined in TGD-treated spontaneously hypertensive rats (SHR) by noninvasive measurements. Echocardiography was performed to assess cardiac function and structure and sirius red staining to evaluate cardiac fibrosis, and the degree of vascular remodeling was evaluated. Additionally, vasoconstriction and relaxation factor expression changes were examined by means of ELISA. Protein expression changes were verified by western blot. Compared with untreated SHR, TGD-treated SHR exhibited cardiovascular traits more akin to those of the normotensive Wistar Kyoto (WKY) rats. That is, they had lower diastolic blood pressure, systolic blood pressure and mean BP, and increased expression of vasodilation factor. We also found that TGD reduces ventricular and vascular remodeling and improves cardiac function in SHR. Finally, we tested the antiapoptosis effect TGD exerts in SHR, ostensibly by upregulating the expression of OPG, TRAIL, and death receptor 5 (DR5) and downregulating caspases 8, 7, and 3. TRAIL may also exert antiapoptotic and prosurvival effects by upregulating AKT expression. Therefore, TGD may reverse cardiovascular remodeling in SHR by upregulating the expression of OPG and TRAIL, upregulating AKT, and inhibiting apoptosis, at least in part. For the first time, we have shown that OPG and TRAIL play complimentary cardioprotective roles in SHR.

Identifiers

PMID33133215
PMCPMC7593748
OpenAlexW3093960804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.